PLEXIUM

Plexium is the premier, next-generation targeted protein degradation (TPD) company. We lead the way in the rational design and discovery of monovalent protein degraders across a wide range of modalities... The opportunities to address the vast undrugged landscape are immense and exciting. We are dedicated to the discovery of new and transformative therapies that bring meaningful benefit to patients with diseases that have limited or no known treatment options. The future of medicine is now and at Plexium... We are a clinical stage drug discovery and development company dedicated to delivering targeted protein degradation therapies in areas of high unmet medical need against difficult-to-drug targets.

Also known as: Plexium, Inc.

Primary location: San Diego United States